CN Stock MarketDetailed Quotes

002728 Teyi Pharmaceutical Group

Watchlist
  • 9.10
  • +0.15+1.68%
Market Closed Dec 27 15:00 CST
4.65BMarket Cap65.94P/E (TTM)

Teyi Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-36.36%384.88M
16.11%407.25M
-19.73%562.59M
-12.49%647.25M
13.65%604.81M
-19.12%350.73M
174.19%700.88M
98.58%739.66M
142.02%532.16M
93.35%433.63M
Transactional financial assets
1,553.85%215M
--107M
--23.01M
----
--13M
----
----
----
----
--10M
Notes receivable and accounts receivable
35.21%132.79M
6.42%116.77M
27.80%148.89M
17.28%156M
-11.25%98.21M
-14.53%109.72M
-9.91%116.5M
5.02%133.02M
-0.32%110.66M
31.87%128.37M
-Notes receivable
228.65%57.02M
30.03%46.91M
22.98%68.84M
47.14%58.2M
-42.06%17.35M
-13.10%36.08M
15.74%55.97M
-20.38%39.55M
-29.89%29.94M
36.91%41.51M
-Accounts receivable
-6.30%75.77M
-5.15%69.85M
32.25%80.05M
4.64%97.81M
0.18%80.87M
-15.21%73.64M
-25.23%60.53M
21.41%93.47M
18.17%80.72M
29.59%86.86M
Other receivables (including interest and dividends)
15.21%1.3M
28.24%1.7M
-69.21%1.2M
-17.52%13.92M
-62.15%1.13M
9.72%1.33M
218.99%3.89M
1,593.46%16.87M
175.53%2.98M
-39.63%1.21M
-Accrued interest receivable
81.88%686.95K
4,725.79%1.21M
-80.78%548.33K
-48.93%1.46M
-78.03%377.7K
--25.1K
--2.85M
--2.85M
--1.72M
----
-Other receivable
----
-62.17%493.39K
----
----
----
7.65%1.3M
----
1,307.08%14.02M
----
-39.63%1.21M
Advance payment
-39.62%18.04M
-53.85%14.27M
-16.75%21.22M
-48.28%14.4M
49.71%29.89M
56.05%30.91M
25.87%25.49M
92.13%27.84M
91.51%19.96M
58.52%19.81M
Inventories
1.91%291.61M
25.43%311.32M
27.44%295.49M
30.55%271.83M
26.08%286.14M
14.86%248.2M
17.75%231.87M
6.61%208.23M
10.88%226.95M
0.51%216.1M
Other current assets
119.45%4.04M
9,316.35%6.83M
45.64%2.88M
-45.92%1.76M
7,501.38%1.84M
-34.84%72.58K
412.00%1.98M
60.96%3.25M
-58.57%24.24K
-94.89%111.4K
Total current assets
1.22%1.05B
30.25%965.14M
-2.34%1.06B
-2.10%1.11B
15.94%1.04B
-8.44%740.97M
70.52%1.08B
58.56%1.13B
63.16%892.74M
46.25%809.23M
Non Current assets
Other non-current financial assets
0.00%13.5M
0.00%13.5M
0.00%13.5M
0.00%13.5M
0.00%13.5M
0.00%13.5M
--13.5M
--13.5M
--13.5M
--13.5M
Investment real estate
-4.99%9.26M
-4.92%9.38M
-5.09%9.51M
-4.81%9.63M
63.55%9.75M
64.45%9.87M
65.74%10.02M
66.22%10.11M
-2.69%5.96M
-2.67%6M
Fixed assets
----
4.90%512.21M
----
----
----
25.59%488.29M
----
-8.95%367.14M
----
-6.95%388.79M
Constru in process
----
2.15%175.64M
----
----
----
-21.85%171.94M
----
41.53%280.88M
----
37.26%220M
Intangible assets
-5.69%141.77M
-1.93%144.93M
-1.82%148.08M
-1.71%151.24M
-4.25%150.32M
-7.72%147.78M
-1.97%150.82M
-1.83%153.87M
9.93%157M
10.21%160.13M
Development expenditure
4.36%14.69M
1.35%14.53M
4.21%13.51M
17.98%13.39M
30.37%14.07M
34.05%14.34M
-19.30%12.97M
-26.29%11.35M
-62.67%10.8M
-62.90%10.7M
Goodwill
-2.43%529.23M
-2.43%529.23M
-2.43%529.23M
-2.43%529.23M
0.00%542.4M
0.00%542.4M
0.00%542.4M
0.00%542.4M
-4.08%542.4M
-4.08%542.4M
Long deferred expense
----
-80.00%17.5K
-66.67%35K
-57.14%52.5K
-50.00%70K
-44.44%87.5K
-40.00%105K
-36.36%122.5K
-33.33%140K
-30.77%157.5K
Deferred tax assets
114.59%26.44M
93.29%22.77M
13.68%17.25M
-2.17%18.4M
-8.46%12.32M
-23.75%11.78M
-4.02%15.17M
9.52%18.81M
-14.89%13.46M
-8.26%15.45M
Other non current assets
32.93%23.51M
7.35%20.49M
11.73%20.64M
-16.21%15.55M
-20.44%17.69M
-12.68%19.09M
-41.79%18.48M
27.41%18.56M
-40.50%22.23M
177.45%21.86M
Total non current assets
1.97%1.44B
1.67%1.44B
-0.30%1.41B
-0.65%1.41B
2.56%1.42B
2.91%1.42B
3.41%1.42B
4.61%1.42B
0.30%1.38B
1.77%1.38B
Total assets
1.66%2.49B
11.47%2.41B
-1.19%2.47B
-1.30%2.51B
7.81%2.45B
-1.29%2.16B
24.62%2.5B
23.20%2.55B
18.19%2.27B
14.66%2.19B
Liabilities
Current liabilities
Short term loan
72.97%640M
22.47%453M
-48.42%296M
-51.71%306M
-41.72%370M
-37.10%369.88M
91.93%573.88M
68.08%633.68M
37.72%634.88M
19.76%588M
Notes payable and accounts payable
-38.22%41M
-29.29%59.58M
0.38%88.64M
8.80%83M
27.19%66.36M
59.39%84.26M
111.95%88.3M
45.75%76.29M
0.55%52.18M
-4.53%52.86M
-Notes payable
-15.91%16.65M
-17.29%24.4M
44.97%44.09M
211.77%41.15M
-6.93%19.8M
91.13%29.5M
592.86%30.41M
57.34%13.2M
-21.18%21.28M
-42.96%15.44M
-Accounts payable
-47.71%24.34M
-35.75%35.18M
-23.05%44.55M
-33.67%41.85M
50.68%46.56M
46.30%54.75M
55.31%57.89M
43.53%63.09M
24.12%30.9M
32.19%37.43M
Contract liabilities
2.83%15.51M
-26.14%13.85M
-60.45%13.5M
-81.44%24.26M
0.80%15.08M
16.32%18.75M
243.00%34.14M
320.70%130.69M
23.13%14.96M
91.48%16.12M
Salaries payable
-8.58%5.85M
5.77%6.93M
-2.28%6.82M
0.22%12.04M
10.43%6.39M
21.55%6.56M
21.33%6.98M
14.28%12.01M
7.87%5.79M
-4.58%5.39M
Taxs payable
-50.57%8.06M
-44.11%6.52M
-88.08%3.56M
39.09%32.16M
-4.14%16.31M
-33.91%11.66M
53.61%29.85M
28.89%23.12M
55.57%17.01M
57.04%17.64M
Other payable (including interest and dividends)
-55.28%2.76M
-40.55%3.11M
-19.34%3.31M
79.12%5.16M
1.02%6.16M
9.37%5.23M
-1.24%4.1M
-16.46%2.88M
1.66%6.1M
-4.07%4.78M
-Interest payable
----
----
----
----
-15.04%3.11M
-15.02%2.16M
-19.90%1.21M
-20.22%272.05K
13.35%3.66M
12.14%2.54M
-Other payable
----
1.28%3.11M
----
----
----
37.04%3.07M
----
-16.04%2.61M
----
-17.59%2.24M
Non current liabilities due within one year
----
----
----
----
--219.73M
--217.65M
--215.5M
--213.5M
----
----
Other current liabilities
2.83%2.02M
-26.20%1.8M
-60.45%1.76M
-81.56%3.15M
0.80%1.96M
16.32%2.44M
243.00%4.44M
323.13%17.07M
23.13%1.95M
91.48%2.1M
Total current liabilities
1.88%715.18M
-23.96%544.78M
-56.79%413.58M
-58.01%465.77M
-4.21%702.01M
4.30%716.42M
151.07%957.19M
123.48%1.11B
33.51%732.87M
18.89%686.89M
Current liabilities
Bonds payable
----
----
----
----
----
----
----
----
5.00%295.81M
5.03%292.13M
Deferred tax liabilities
5.03%15.18M
4.97%15.26M
4.90%15.34M
4.84%15.42M
54.54%14.46M
45.29%14.54M
37.38%14.62M
30.52%14.71M
-20.51%9.35M
-19.35%10.01M
Long term deferred income
-5.85%19.31M
-6.86%19.77M
11.80%20.02M
12.20%20.77M
7.29%20.51M
7.65%21.23M
3.61%17.91M
57.99%18.51M
63.79%19.11M
64.37%19.72M
Total non current liabilities
-1.35%34.49M
-2.05%35.03M
8.70%35.36M
8.94%36.19M
-89.22%34.97M
-88.89%35.77M
-89.72%32.53M
-89.22%33.22M
0.66%324.28M
5.16%321.85M
Total liabilities
1.72%749.68M
-22.92%579.82M
-54.64%448.94M
-56.06%501.95M
-30.29%736.97M
-25.43%752.18M
41.85%989.72M
42.01%1.14B
21.36%1.06B
14.14%1.01B
Shareholders equity
Paid-in capital
49.68%510.7M
59.10%510.69M
59.12%364.74M
59.13%364.69M
53.93%341.2M
44.82%320.99M
3.41%229.22M
3.40%229.18M
8.87%221.66M
8.87%221.66M
Other equity instruments
----
----
----
----
-29.20%38.32M
-29.02%38.42M
-28.89%38.49M
-28.76%38.58M
-0.12%54.13M
-0.13%54.13M
Capital reserve funds
13.87%836.88M
72.32%836.84M
70.40%982.43M
70.51%982M
59.40%734.96M
5.32%485.63M
25.04%576.53M
24.95%575.92M
57.04%461.1M
57.06%461.08M
Surplus reserve funds
22.33%140.18M
22.33%140.18M
22.33%140.18M
22.33%140.18M
3.40%114.59M
3.40%114.59M
3.40%114.59M
3.40%114.59M
8.91%110.82M
8.91%110.82M
Retained profit
-28.69%341.14M
-23.58%337.82M
-3.26%526.65M
17.90%517.5M
32.06%478.4M
35.62%442.04M
19.85%544.4M
7.43%438.92M
-7.96%362.25M
-10.95%325.95M
Less:Treasury stock
--93.86M
--3.98M
----
----
----
----
----
----
----
----
Specific reserves
5.21%6.55M
4.72%6.48M
6.16%6.41M
6.12%6.31M
4.94%6.23M
6.01%6.19M
5.99%6.04M
6.42%5.95M
8.55%5.94M
7.49%5.83M
Shareholders equity without minority interests
1.63%1.74B
29.84%1.83B
33.87%2.02B
43.30%2.01B
40.94%1.71B
19.36%1.41B
15.42%1.51B
11.21%1.4B
15.56%1.22B
15.12%1.18B
Total shareholder equity
1.63%1.74B
29.84%1.83B
33.87%2.02B
43.30%2.01B
40.94%1.71B
19.36%1.41B
15.42%1.51B
11.21%1.4B
15.56%1.22B
15.12%1.18B
Total liabilityies and equity
1.66%2.49B
11.47%2.41B
-1.19%2.47B
-1.30%2.51B
7.81%2.45B
-1.29%2.16B
24.62%2.5B
23.20%2.55B
18.19%2.27B
14.66%2.19B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -36.36%384.88M16.11%407.25M-19.73%562.59M-12.49%647.25M13.65%604.81M-19.12%350.73M174.19%700.88M98.58%739.66M142.02%532.16M93.35%433.63M
Transactional financial assets 1,553.85%215M--107M--23.01M------13M------------------10M
Notes receivable and accounts receivable 35.21%132.79M6.42%116.77M27.80%148.89M17.28%156M-11.25%98.21M-14.53%109.72M-9.91%116.5M5.02%133.02M-0.32%110.66M31.87%128.37M
-Notes receivable 228.65%57.02M30.03%46.91M22.98%68.84M47.14%58.2M-42.06%17.35M-13.10%36.08M15.74%55.97M-20.38%39.55M-29.89%29.94M36.91%41.51M
-Accounts receivable -6.30%75.77M-5.15%69.85M32.25%80.05M4.64%97.81M0.18%80.87M-15.21%73.64M-25.23%60.53M21.41%93.47M18.17%80.72M29.59%86.86M
Other receivables (including interest and dividends) 15.21%1.3M28.24%1.7M-69.21%1.2M-17.52%13.92M-62.15%1.13M9.72%1.33M218.99%3.89M1,593.46%16.87M175.53%2.98M-39.63%1.21M
-Accrued interest receivable 81.88%686.95K4,725.79%1.21M-80.78%548.33K-48.93%1.46M-78.03%377.7K--25.1K--2.85M--2.85M--1.72M----
-Other receivable -----62.17%493.39K------------7.65%1.3M----1,307.08%14.02M-----39.63%1.21M
Advance payment -39.62%18.04M-53.85%14.27M-16.75%21.22M-48.28%14.4M49.71%29.89M56.05%30.91M25.87%25.49M92.13%27.84M91.51%19.96M58.52%19.81M
Inventories 1.91%291.61M25.43%311.32M27.44%295.49M30.55%271.83M26.08%286.14M14.86%248.2M17.75%231.87M6.61%208.23M10.88%226.95M0.51%216.1M
Other current assets 119.45%4.04M9,316.35%6.83M45.64%2.88M-45.92%1.76M7,501.38%1.84M-34.84%72.58K412.00%1.98M60.96%3.25M-58.57%24.24K-94.89%111.4K
Total current assets 1.22%1.05B30.25%965.14M-2.34%1.06B-2.10%1.11B15.94%1.04B-8.44%740.97M70.52%1.08B58.56%1.13B63.16%892.74M46.25%809.23M
Non Current assets
Other non-current financial assets 0.00%13.5M0.00%13.5M0.00%13.5M0.00%13.5M0.00%13.5M0.00%13.5M--13.5M--13.5M--13.5M--13.5M
Investment real estate -4.99%9.26M-4.92%9.38M-5.09%9.51M-4.81%9.63M63.55%9.75M64.45%9.87M65.74%10.02M66.22%10.11M-2.69%5.96M-2.67%6M
Fixed assets ----4.90%512.21M------------25.59%488.29M-----8.95%367.14M-----6.95%388.79M
Constru in process ----2.15%175.64M-------------21.85%171.94M----41.53%280.88M----37.26%220M
Intangible assets -5.69%141.77M-1.93%144.93M-1.82%148.08M-1.71%151.24M-4.25%150.32M-7.72%147.78M-1.97%150.82M-1.83%153.87M9.93%157M10.21%160.13M
Development expenditure 4.36%14.69M1.35%14.53M4.21%13.51M17.98%13.39M30.37%14.07M34.05%14.34M-19.30%12.97M-26.29%11.35M-62.67%10.8M-62.90%10.7M
Goodwill -2.43%529.23M-2.43%529.23M-2.43%529.23M-2.43%529.23M0.00%542.4M0.00%542.4M0.00%542.4M0.00%542.4M-4.08%542.4M-4.08%542.4M
Long deferred expense -----80.00%17.5K-66.67%35K-57.14%52.5K-50.00%70K-44.44%87.5K-40.00%105K-36.36%122.5K-33.33%140K-30.77%157.5K
Deferred tax assets 114.59%26.44M93.29%22.77M13.68%17.25M-2.17%18.4M-8.46%12.32M-23.75%11.78M-4.02%15.17M9.52%18.81M-14.89%13.46M-8.26%15.45M
Other non current assets 32.93%23.51M7.35%20.49M11.73%20.64M-16.21%15.55M-20.44%17.69M-12.68%19.09M-41.79%18.48M27.41%18.56M-40.50%22.23M177.45%21.86M
Total non current assets 1.97%1.44B1.67%1.44B-0.30%1.41B-0.65%1.41B2.56%1.42B2.91%1.42B3.41%1.42B4.61%1.42B0.30%1.38B1.77%1.38B
Total assets 1.66%2.49B11.47%2.41B-1.19%2.47B-1.30%2.51B7.81%2.45B-1.29%2.16B24.62%2.5B23.20%2.55B18.19%2.27B14.66%2.19B
Liabilities
Current liabilities
Short term loan 72.97%640M22.47%453M-48.42%296M-51.71%306M-41.72%370M-37.10%369.88M91.93%573.88M68.08%633.68M37.72%634.88M19.76%588M
Notes payable and accounts payable -38.22%41M-29.29%59.58M0.38%88.64M8.80%83M27.19%66.36M59.39%84.26M111.95%88.3M45.75%76.29M0.55%52.18M-4.53%52.86M
-Notes payable -15.91%16.65M-17.29%24.4M44.97%44.09M211.77%41.15M-6.93%19.8M91.13%29.5M592.86%30.41M57.34%13.2M-21.18%21.28M-42.96%15.44M
-Accounts payable -47.71%24.34M-35.75%35.18M-23.05%44.55M-33.67%41.85M50.68%46.56M46.30%54.75M55.31%57.89M43.53%63.09M24.12%30.9M32.19%37.43M
Contract liabilities 2.83%15.51M-26.14%13.85M-60.45%13.5M-81.44%24.26M0.80%15.08M16.32%18.75M243.00%34.14M320.70%130.69M23.13%14.96M91.48%16.12M
Salaries payable -8.58%5.85M5.77%6.93M-2.28%6.82M0.22%12.04M10.43%6.39M21.55%6.56M21.33%6.98M14.28%12.01M7.87%5.79M-4.58%5.39M
Taxs payable -50.57%8.06M-44.11%6.52M-88.08%3.56M39.09%32.16M-4.14%16.31M-33.91%11.66M53.61%29.85M28.89%23.12M55.57%17.01M57.04%17.64M
Other payable (including interest and dividends) -55.28%2.76M-40.55%3.11M-19.34%3.31M79.12%5.16M1.02%6.16M9.37%5.23M-1.24%4.1M-16.46%2.88M1.66%6.1M-4.07%4.78M
-Interest payable -----------------15.04%3.11M-15.02%2.16M-19.90%1.21M-20.22%272.05K13.35%3.66M12.14%2.54M
-Other payable ----1.28%3.11M------------37.04%3.07M-----16.04%2.61M-----17.59%2.24M
Non current liabilities due within one year ------------------219.73M--217.65M--215.5M--213.5M--------
Other current liabilities 2.83%2.02M-26.20%1.8M-60.45%1.76M-81.56%3.15M0.80%1.96M16.32%2.44M243.00%4.44M323.13%17.07M23.13%1.95M91.48%2.1M
Total current liabilities 1.88%715.18M-23.96%544.78M-56.79%413.58M-58.01%465.77M-4.21%702.01M4.30%716.42M151.07%957.19M123.48%1.11B33.51%732.87M18.89%686.89M
Current liabilities
Bonds payable --------------------------------5.00%295.81M5.03%292.13M
Deferred tax liabilities 5.03%15.18M4.97%15.26M4.90%15.34M4.84%15.42M54.54%14.46M45.29%14.54M37.38%14.62M30.52%14.71M-20.51%9.35M-19.35%10.01M
Long term deferred income -5.85%19.31M-6.86%19.77M11.80%20.02M12.20%20.77M7.29%20.51M7.65%21.23M3.61%17.91M57.99%18.51M63.79%19.11M64.37%19.72M
Total non current liabilities -1.35%34.49M-2.05%35.03M8.70%35.36M8.94%36.19M-89.22%34.97M-88.89%35.77M-89.72%32.53M-89.22%33.22M0.66%324.28M5.16%321.85M
Total liabilities 1.72%749.68M-22.92%579.82M-54.64%448.94M-56.06%501.95M-30.29%736.97M-25.43%752.18M41.85%989.72M42.01%1.14B21.36%1.06B14.14%1.01B
Shareholders equity
Paid-in capital 49.68%510.7M59.10%510.69M59.12%364.74M59.13%364.69M53.93%341.2M44.82%320.99M3.41%229.22M3.40%229.18M8.87%221.66M8.87%221.66M
Other equity instruments -----------------29.20%38.32M-29.02%38.42M-28.89%38.49M-28.76%38.58M-0.12%54.13M-0.13%54.13M
Capital reserve funds 13.87%836.88M72.32%836.84M70.40%982.43M70.51%982M59.40%734.96M5.32%485.63M25.04%576.53M24.95%575.92M57.04%461.1M57.06%461.08M
Surplus reserve funds 22.33%140.18M22.33%140.18M22.33%140.18M22.33%140.18M3.40%114.59M3.40%114.59M3.40%114.59M3.40%114.59M8.91%110.82M8.91%110.82M
Retained profit -28.69%341.14M-23.58%337.82M-3.26%526.65M17.90%517.5M32.06%478.4M35.62%442.04M19.85%544.4M7.43%438.92M-7.96%362.25M-10.95%325.95M
Less:Treasury stock --93.86M--3.98M--------------------------------
Specific reserves 5.21%6.55M4.72%6.48M6.16%6.41M6.12%6.31M4.94%6.23M6.01%6.19M5.99%6.04M6.42%5.95M8.55%5.94M7.49%5.83M
Shareholders equity without minority interests 1.63%1.74B29.84%1.83B33.87%2.02B43.30%2.01B40.94%1.71B19.36%1.41B15.42%1.51B11.21%1.4B15.56%1.22B15.12%1.18B
Total shareholder equity 1.63%1.74B29.84%1.83B33.87%2.02B43.30%2.01B40.94%1.71B19.36%1.41B15.42%1.51B11.21%1.4B15.56%1.22B15.12%1.18B
Total liabilityies and equity 1.66%2.49B11.47%2.41B-1.19%2.47B-1.30%2.51B7.81%2.45B-1.29%2.16B24.62%2.5B23.20%2.55B18.19%2.27B14.66%2.19B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Macrobiotic NMN
Macrobiotic NMN
Intraday+1.65%
Traditional Chinese Medicine Concept
Traditional Chinese Medicine Concept
Intraday+0.83%
Virus Prevention
Virus Prevention
Intraday+0.51%